A Novel Fluorescent Aptamer Sensor with DNAzyme Signal Amplification for the Detection of CEA in Blood

Sensors (Basel). 2023 Jan 24;23(3):1317. doi: 10.3390/s23031317.

Abstract

Carcinoembryonic antigen (CEA) is a tumor-specific biomarker; however, its low levels in the early stages of cancer make it difficult to detect. To address the need for analysis of ultra-low-level substances, we designed and synthesized a fluorescent aptamer sensor with DNAzyme signal amplification and used it for the detection of CEA in blood. In the presence of the target protein, the aptamer sequence in the recognition probe binds to the target protein and opens the hairpin structure, hybridizes with the primer and triggers a polymerization reaction in the presence of polymerase to generate double-stranded DNA with two restriction endonuclease Nb.BbvCl cleavage sites. At the same time, the target protein is displaced and continues to bind to another recognition probe, triggering a new round of polymerization reaction, forming a cyclic signal amplification triggered by the target. The experimental results show that the blood detection with CEA has a high sensitivity and a wide detection range. The detection range: 10 fg/mL~10 ng/mL, with a detection limit of 5.2 fg/mL. In addition, the sensor can be used for the analysis of complex biological samples such as blood.

Keywords: DNAzyme; carcinoembryonic antigen; fluorescent aptamer sensor; signal amplification.

MeSH terms

  • Aptamers, Nucleotide* / chemistry
  • Biosensing Techniques* / methods
  • Carcinoembryonic Antigen / analysis
  • Coloring Agents
  • DNA
  • DNA, Catalytic* / chemistry
  • Limit of Detection

Substances

  • DNA, Catalytic
  • Carcinoembryonic Antigen
  • Aptamers, Nucleotide
  • DNA
  • Coloring Agents